RedHill Biopharma Announces Positive Top-Line Safety and Effic...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
TEL AVIV, Israel and RALEIGH, N.C., Dec. 31, 2020 /PRNewswire-AsiaNet/ -- - Preliminary data from the non-powered U.S. Phase 2 study of 40 hospitalized patients shows that orally-administered opaganib was safe, with no material safety differences between opaganib and control arms- Consistent trends demonstrate great...
Authors: LATEST ASIANET NEWS RELEASES